SB8

null · Samsung Bioepis Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SB8, covering 2019-06-03 to 2019-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic, Safety, Tolerability, and Immunogenicity Study of SB8 in Healthy Male Subjects [Phase 1]